Digital Breast Tomosynthesis (DBT) to Improve Assessment of Resection Margins in Invasive Breast Cancer
N/A
The challenge of breast conserving surgery (BCS) is to obtain free resectio...
Status
Completed
Location
Department og Plastic- and Breast Surgery
Start Date
2020-09-17
Trial ID
NCT04478669
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer
PHASE3
A randomized multi-arm study evaluating the efficacy and safety of nivoluma...